• A20, Oxidized DNA, and Acute Kidney Injury

  2026-08-17

  The reference study identifies oxidized self-DNA as an inflammatory driver in acute kidney injury and shows that A20 limits this response by restraining STING signaling and NLRP3-mediated pyroptosis. Its mechanistic and peptide-validation data position the A20–NEK7 interaction as a potential therapeutic entry point, while also providing a framework for interpreting inflammasome modulation in related disease models.

• Berberine Hydrochloride: AMPK Research Workflows

  2026-08-17

  Berberine hydrochloride is a defined chemical probe for connecting AMPK-driven metabolic regulation with LDL receptor, mitochondrial, oxidative-stress, and cancer readouts. This workflow shows how to move from reproducible DMSO stocks to cell-based assays, cardiotoxicity models, and troubleshooting decisions without overextending evidence from botanical extracts.

• Sitagliptin Phosphate Monohydrate in Gut Signaling

  2026-08-16

  Sitagliptin phosphate monohydrate is a selective DPP-4 inhibitor that can help separate incretin-dependent glucose regulation from intestinal stretch signaling. This article translates recent gut mechanosensation findings into practical assay and study-design decisions.

• Hypoxia and Immunometabolism in the Tumor Microenvironment

  2026-08-15

  This 2025 review frames tumor hypoxia and immunometabolism as a reciprocal system in which oxygen limitation, nutrient competition, and HIF signaling reshape both malignant and immune-cell behavior. Its main practical implication is that tumor progression and therapeutic response should be interpreted through coordinated metabolic, immune, and redox measurements rather than through isolated molecular endpoints.

• 3-Deazaneplanocin (DZNep) in Cancer Research

  2026-08-14

  3-Deazaneplanocin (DZNep) connects S-adenosylhomocysteine hydrolase inhibition with functional EZH2 suppression, making it useful for apoptosis induction in AML cells, hepatocellular carcinoma research, and cancer stem cell targeting. This workflow-driven guide covers dose design, epigenetic readouts, model stratification, and troubleshooting for reproducible experiments.

• Vaccinia F1L Evasion of NLRP1 Activation

  2026-08-14

  The reference study identifies vaccinia virus F1L as a viral antagonist that suppresses dsRNA- and ribotoxic stress-driven NLRP1 inflammasome activation while leaving DPP9-inhibition-mediated activation intact. Its genetic, cellular, and translation-focused experiments place F1L function partly upstream of ZAKα, clarifying how vaccinia virus limits epithelial innate immune signaling.

• Rucaparib and the Logic of DNA Repair Dependency

  2026-08-13

  Rucaparib (AG-014699) is examined here as a causal tool for DNA damage response research, not simply as a PARP inhibitor. The article connects repair-pathway phenotypes with a key Pol II degradation study and translates that distinction into more rigorous assay design.

• Talabostat mesylate: CARD8 and FAP Assays

  2026-08-13

  Talabostat mesylate, also called PT-100 or Val-boroPro, supports complementary workflows for DPP4/FAP biology, tumor-stroma studies, and CARD8-dependent pyroptosis. This guide connects FAP-expressing models with resting human T-cell assays while emphasizing controls that prevent mistaking broad DPP engagement or solvent effects for pathway-specific biology.

• PMSF in Cardiomyocyte Ablation Research

  2026-08-12

  Explore how Phenylmethanesulfonyl fluoride (PMSF) can strengthen protein-level measurements after microsecond pulsed electric field ablation. This article distinguishes proteolysis control from apoptosis mechanism and translates recent cardiomyocyte findings into practical assay decisions.

• Moesin in Sepsis: Endothelial Injury Biomarker

  2026-08-12

  The reference study identifies circulating moesin (MSN) as a candidate biomarker of endothelial injury and sepsis severity, linking serum levels with SOFA scores, procalcitonin, and experimental lung damage. Its combination of patient samples, mouse sepsis models, and mechanistic endothelial-cell experiments suggests that MSN is not only associated with vascular dysfunction but may also participate in Rock1/MLC and NF-κB signaling.

• Canagliflozin Workflows for Renal Mitochondria

  2026-08-11

  Canagliflozin enables researchers to connect renal glucose handling with proximal tubular mitochondrial structure and bioenergetics. This practical guide outlines formulation, cell-based, animal-model, imaging, and respiration workflows while emphasizing sex-aware analysis and troubleshooting.

• Predicting siRNA Codelivery with Netarsudil

  2026-08-11

  Slaughter and colleagues developed a quantitative screening and machine-learning framework to predict which ionizable drugs can complex siRNA and support nanoparticle encapsulation. Netarsudil was identified as a high-performing candidate and experimentally evaluated with CTGF-targeting siRNA in fibrotic human trabecular meshwork cells, linking formulation prediction to changes in gene expression and actin organization.

• NVP-BGJ398 Phosphate for Reliable FGFR Assays

  2026-08-10

  Learn how NVP-BGJ398 phosphate, SKU A3673, can improve experimental consistency in FGFR-driven viability, proliferation, and cytotoxicity workflows. This scenario-based guide connects formulation, assay design, pathway validation, and evidence from cancer and skeletal-disease models.

• SIS3 (Smad3 Inhibitor) in Fibrosis Research

  2026-08-09

  SIS3 is a selective Smad3 inhibitor for dissecting TGF-β signaling in cellular and animal research. Product documentation describes pathway-selective effects, fibrosis-related activity, and preclinical use, while independent literature supports canonical TGF-β/SMAD3 signaling as a disease-relevant axis in lung adenocarcinoma.

• GPCR Control of Kir7.1 Glycosylation and Activity

  2026-08-08

  Carrington et al. show that GPCRs regulate Kir7.1 through a mechanism distinct from the canonical Gβγ-mediated control of GIRK channels: most receptors tested reduce complex glycosylation and channel activity without reducing surface abundance. Site-directed mutagenesis and analysis of the disease-associated L241P variant link Kir7.1 glycosylation to conductance and open probability, providing a mechanistic framework for studying channel dysfunction in retinal and other excitable tissues.

8104 records 7/541 page Previous Next First page 上5页 678910 下5页 Last page